The largest holder of GE HealthCare Technologies stock is Dodge & Cox, with 47.3 million shares (10.48% of the company), worth about $3.37 billion as of September 25, 2026. The 10 largest holders together own 54.2%.
In Q2 2026, 1,289 institutional holdings reports listed 436.0 million shares worth $25.90 billion, up 9.3% in shares from Q1 2026.
Insiders reported 59 transactions in the last two years: 3 sales worth $573,286 and 7 purchases. The newest one on file is from May 12, 2026 (Hochman Rodney F, Director).
Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through May 12, 2026.

2026Q2
| Holder | Shares | % of company | Value |
|---|---|---|---|
| Dodge & Cox | 47.3 million | 10.48% | $3.4B |
| Dodge & Cox | 37.9 million | 8.38% | $2.7B |
| Vanguard Capital Management LLC | 29.7 million | 6.58% | $2.1B |
| BlackRock Advisors LLC | 28.7 million | 6.36% | $2.0B |
| State Street Corporation | 20.9 million | 4.62% | $1.5B |
| Vanguard Portfolio Management LLC | 20.3 million | 4.49% | $1.4B |
| Invesco Advisers, Inc. | 18.3 million | 4.05% | $1.3B |
| Harris Associates LP | 15.3 million | 3.39% | $1.1B |
| Barrow, Hanley, Mewhinney & Strauss LLC | 13.5 million | 2.98% | $958.0M |
| Geode Capital Management LLC | 12.9 million | 2.85% | $917.0M |
As of September 25, 2026.
| Quarter | Reports | Shares | Value |
|---|---|---|---|
| Q2 2026 | 1,289 | 436.0 million | $25.9B |
| Q1 2026 | 1,334 | 399.0 million | $28.3B |
| Q4 2025 | 1,405 | 416.0 million | $33.8B |
| Q3 2025 | 1,364 | 384.0 million | $28.8B |
| Q2 2025 | 1,391 | 385.0 million | $28.5B |
| Q1 2025 | 1,446 | 383.0 million | $30.9B |
| Q4 2024 | 1,404 | 389.0 million | $30.4B |
| Q3 2024 | 1,346 | 383.0 million | $35.8B |
Shares and value held by institutions that file quarterly holdings reports (options not included).
| Insider | Date | Title | Transaction | Value |
|---|---|---|---|---|
| Hochman Rodney F | May 12, 2026 | Director | Purchase at price 62.03 per share. | $100,365 |
| Yang Watkin Phoebe L | May 8, 2026 | Director | Purchase at price 63.01 per share. | $63,006 |
| Culp Henry Lawrence Jr. | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Lesjak Catherine Anne | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Hochman Rodney F | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Madden Anne T | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Yang Watkin Phoebe L | May 7, 2026 | Director | Stock Award(Grant) at price 0.00 per share. | – |
| Culp Henry Lawrence Jr. | May 6, 2026 | Director | Purchase at price 61.88 per share. | $5.0M |
| Stromberg William J | May 6, 2026 | Director | Purchase at price 61.69 per share. | $61,689 |
| Saccaro James | May 1, 2026 | Chief Financial Officer | Purchase at price 60.60 per share. | $200,585 |
| Arduini Peter J | Apr 30, 2026 | Chief Executive Officer | Purchase at price 59.92 per share. | $249,827 |
| Jimenez Frank R | Apr 30, 2026 | General Counsel | Purchase at price 60.45 per share. | $105,788 |
Newest 12 of 59 insider transactions in the last two years.
Dodge & Cox, with 10.48% of the company (as of September 25, 2026). Next: Dodge & Cox (8.38%) and Vanguard Capital Management LLC (6.58%).
1,289 institutional holdings reports listed GE HealthCare Technologies shares in Q2 2026, 436.0 million shares in all worth $25.90 billion.
In the last two years insiders reported 3 sales and 7 purchases (59 transactions in all); the newest on file is from May 12, 2026.